Skip to main content

Advertisement

Log in

The incremental risk of fragility fractures in aging men

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Introduction

While the United States Preventative Services Task Force recommends osteoporosis screening for women 65 years and older, there is no definitive recommendation for routine osteoporosis screening in men. The purpose of this study was to determine the age at which the odds of fragility fractures (FFx) increase in men to help guide future policy discussions evaluating an optimal screening strategy in this population.

Methods

Men older than 49 years were identified in the PearlDiver Patient Records Database. Patients were excluded if they had a prior fragility fracture, if they were at high risk for osteoporosis due to comorbidities, or if they carried a diagnosis of and/or were on treatment for osteoporosis. The prevalence of FFx was trended for each age group. A stratum-specific likelihood ratio (SSLR) analysis was conducted to identify data-driven strata that maximize the incremental FFx risk by age for men. Logistic regression analyses controlling for potential confounders were conducted to test these identified strata.

Results

The incidence of FFx started to increase after the age of 64 years for men. Further, the identified data-driven age strata associated with a significant and incremental difference in fragility fractures were the following: 50–64, 65–69, 70–72, 73–75, 76–78, 79–80, and 81+. When compared to the youngest age stratum (50–64 years), multivariable regression showed the risk of fragility fracture incrementally increased starting in those aged 70–72 (RR, 1.31; 95% CI. 1.21–1.46; p < 0.001) with the highest risk in those aged 81+ (RR, 5.35; 95% CI, 5.10–5.62; p < 0.001).

Conclusion

In men without a pre-existing history of osteoporosis, the risk of fragility fractures starts to increase after the age of 70. Further work building upon these data may help to identify a specific age at which routine bone health screening in males can help to minimize fractures and their associated morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The database utilized for this study does not permit individual patient information to users but provides aggregate information. Thus, the authors are unable to provide individual patient information from the database.

References

  1. Han RJ, Sing DC, Feeley BT et al (2016) Proximal humerus fragility fractures: recent trends in nonoperative and operative treatment in the Medicare population. J Shoulder Elbow Surg 25:256–261. https://doi.org/10.1016/j.jse.2015.07.015

    Article  PubMed  Google Scholar 

  2. Friedman SM, Mendelson DA (2014) Epidemiology of fragility fractures. Clin Geriatr Med 30:175–181. https://doi.org/10.1016/j.cger.2014.01.001

    Article  PubMed  Google Scholar 

  3. Cohn MR, Gianakos AL, Grueter K et al (2018) Update on the comprehensive approach to fragility fractures. J Orthop Trauma 32:480–490. https://doi.org/10.1097/BOT.0000000000001244

    Article  PubMed  Google Scholar 

  4. Nayak S, Greenspan SL (2016) Cost-effectiveness of osteoporosis screening strategies for men. J Bone Miner Res 31:1189–1199. https://doi.org/10.1002/jbmr.2784

    Article  PubMed  Google Scholar 

  5. Williams SA, Daigle SG, Weiss R et al (2021) Economic burden of osteoporosis-related fractures in the US Medicare Population. Ann Pharmacother 55:821–829. https://doi.org/10.1177/1060028020970518

    Article  PubMed  Google Scholar 

  6. Valentin G, Friis K, Nielsen CP et al (2021) Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study. Osteoporos Int 32:63–73. https://doi.org/10.1007/s00198-020-05540-8

    Article  CAS  PubMed  Google Scholar 

  7. US Preventive Services Task Force, Curry SJ, Krist AH et al (2018) Screening for osteoporosis to prevent fractures: US Preventive Services Task Force Recommendation Statement. JAMA 319:2521–2531. https://doi.org/10.1001/jama.2018.7498

    Article  Google Scholar 

  8. Mears SC, Kates SL (2015) A guide to improving the care of patients with fragility fractures, Edition 2. Geriatr Orthop Surg Rehabil 6:58–120. https://doi.org/10.1177/2151458515572697

    Article  PubMed  PubMed Central  Google Scholar 

  9. Armas LAG, Recker RR (2012) Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am 41:475–486. https://doi.org/10.1016/j.ecl.2012.04.006

    Article  CAS  PubMed  Google Scholar 

  10. Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475. https://doi.org/10.1359/jbmr.061113

    Article  PubMed  Google Scholar 

  11. Reginster J-Y, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:S4–S9. https://doi.org/10.1016/j.bone.2005.11.024

    Article  PubMed  Google Scholar 

  12. Khosla S, Shane E (2016) A crisis in the treatment of osteoporosis. J Bone Miner Res 31:1485–1487. https://doi.org/10.1002/jbmr.2888

    Article  PubMed  Google Scholar 

  13. Alswat KA (2017) Gender disparities in osteoporosis. J Clin Med Res 9:382–387. https://doi.org/10.14740/jocmr2970w

    Article  PubMed  PubMed Central  Google Scholar 

  14. Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573–1579. https://doi.org/10.1001/jama.2009.1462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Viswanathan VK, Shetty AP, Rai N et al (2023) What is the role of CT-based Hounsfield unit assessment in the evaluation of bone mineral density in patients undergoing 1- or 2-level lumbar spinal fusion for degenerative spinal pathologies?: a prospective study. Spine J. https://doi.org/10.1016/j.spinee.2023.05.015

  17. Haentjens P, Magaziner J, Colón-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380–390. https://doi.org/10.7326/0003-4819-152-6-201003160-00008

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521. https://doi.org/10.1001/jama.2009.50

    Article  CAS  PubMed  Google Scholar 

  19. Trombetti A, Herrmann F, Hoffmeyer P et al (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731–737. https://doi.org/10.1007/s001980200100

    Article  CAS  PubMed  Google Scholar 

  20. Rabenda V, Vanoverloop J, Fabri V et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90:2142–2148. https://doi.org/10.2106/JBJS.G.00864

    Article  PubMed  Google Scholar 

  21. Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555–1562. https://doi.org/10.2106/JBJS.N.01275

    Article  PubMed  Google Scholar 

  22. García-Sempere A, Hurtado I, Sanfélix-Genovés J et al (2017) Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci Rep 7:11784. https://doi.org/10.1038/s41598-017-10899-6

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  23. Morin S, Lix LM, Azimaee M et al (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439–2448. https://doi.org/10.1007/s00198-010-1480-2

    Article  CAS  PubMed  Google Scholar 

  24. Bouxsein ML, Melton LJ, Riggs BL et al (2006) Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res 21:1475–1482. https://doi.org/10.1359/jbmr.060606

    Article  PubMed  Google Scholar 

  25. Ahmed LA, Center JR, Bjørnerem A et al (2013) Progressively increasing fracture risk with advancing age after initial incident fragility fracture: the Tromsø study. J Bone Miner Res 28:2214–2221. https://doi.org/10.1002/jbmr.1952

    Article  PubMed  Google Scholar 

  26. Papaioannou A, Kennedy CC, Ioannidis G et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19:581–587. https://doi.org/10.1007/s00198-007-0483-0

    Article  CAS  PubMed  Google Scholar 

  27. Bliuc D, Alarkawi D, Nguyen TV et al (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30:637–646. https://doi.org/10.1002/jbmr.2393

    Article  PubMed  Google Scholar 

  28. Bennett MJ, Center JR, Perry L (2023) Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study. Osteoporos Int 34:1249–1262. https://doi.org/10.1007/s00198-023-06748-0

    Article  PubMed  PubMed Central  Google Scholar 

  29. Manolagas SC (2018) The quest for osteoporosis mechanisms and rational therapies: how far we’ve come, how much further we need to go. J Bone Miner Res 33:371–385. https://doi.org/10.1002/jbmr.3400

    Article  PubMed  Google Scholar 

  30. Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277:650–661. https://doi.org/10.1111/joim.12369

    Article  CAS  PubMed  Google Scholar 

  31. Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 104:29–38. https://doi.org/10.1016/j.bone.2017.01.024

    Article  PubMed  PubMed Central  Google Scholar 

  32. Agarwal AR, Cohen JS, Jorgensen A et al (2023) Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019. Osteoporos Int 34:379–385. https://doi.org/10.1007/s00198-022-06622-5

    Article  PubMed  Google Scholar 

  33. Kreulen RT, Agarwal AR, Nayar SK et al (2022) SLAP repair and bicep tenodesis: a comparison of utilization and revision rates for SLAP tears. JSES Int 7:290–295. https://doi.org/10.1016/j.jseint.2022.11.001

    Article  PubMed  PubMed Central  Google Scholar 

  34. Agarwal AR, Ahmed AF, Stadecker M et al (2023) Trends in venous thromboembolism after shoulder arthroplasty in the United States: analysis following the 2009 American Academy of Orthopaedic Surgeons Clinical Practical Guidelines. J Am Acad Orthop Surg 31:364–372. https://doi.org/10.5435/JAAOS-D-22-00825

    Article  PubMed  Google Scholar 

  35. Ross BJ, Ross AJ, Lee OC et al (2022) Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study. Osteoporos Int 33:1999–2010. https://doi.org/10.1007/s00198-022-06451-6

    Article  CAS  PubMed  Google Scholar 

  36. Peirce JC, Cornell RG (1993) Integrating stratum-specific likelihood ratios with the analysis of ROC curves. Med Decis Making 13:141–151. https://doi.org/10.1177/0272989X9301300208

    Article  CAS  PubMed  Google Scholar 

  37. Gu A, Fassihi SC, Wessel LE et al (2021) Comparison of revision risk based on timing of knee arthroscopy prior to total knee arthroplasty. J Bone Joint Surg Am 103:660–667. https://doi.org/10.2106/JBJS.20.00218

    Article  PubMed  Google Scholar 

  38. Harris AB, Wang KY, Reddy R et al (2022) A novel method for stratification of major complication risk using body mass index thresholds for patients undergoing total hip arthroplasty: a national cohort of 224,413 patients. J Arthroplasty 37:2049–2052. https://doi.org/10.1016/j.arth.2022.04.030

    Article  PubMed  Google Scholar 

  39. Navarro SM, Haeberle HS, Mont MA et al (2019) Stratum-specific likelihood ratio analysis: an evidence-based and pragmatic approach to meaningful thresholds in lower extremity Arthroplasty. Surg Technol Int 34:415–420

    PubMed  Google Scholar 

  40. Haeberle HS, Navarro SM, Frankel WC et al (2018) Evidence-based thresholds for the volume and cost relationship in total hip arthroplasty: outcomes and economies of scale. J Arthroplasty 33:2398–2404. https://doi.org/10.1016/j.arth.2018.02.093

    Article  PubMed  Google Scholar 

  41. Ramkumar PN, Navarro SM, Haeberle HS et al (2017) Evidence-based thresholds for the volume-value relationship in shoulder arthroplasty: outcomes and economies of scale. J Shoulder Elbow Surg 26:1399–1406. https://doi.org/10.1016/j.jse.2017.05.019

    Article  PubMed  Google Scholar 

  42. Pisani P, Renna MD, Conversano F et al (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7:171–181. https://doi.org/10.5312/wjo.v7.i3.171

    Article  PubMed  PubMed Central  Google Scholar 

  43. Watts NB, Adler RA, Bilezikian JP et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:1802–1822. https://doi.org/10.1210/jc.2011-3045

    Article  CAS  PubMed  Google Scholar 

  44. Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861–1870. https://doi.org/10.1210/jc.2011-3058

    Article  CAS  PubMed  Google Scholar 

  45. Schousboe JT, Taylor BC, Fink HA et al (2007) Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298:629–637. https://doi.org/10.1001/jama.298.6.629

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A.R. Agarwal.

Ethics declarations

Conflict of interest

Agarwal, Tarawneh, Gu, Jordan, and Moseley have no conflicts of interests to disclose. Debritz is a paid consultant for Avenos and has stock/stock options with Johnson & Johnson. Golladay is a board/committee member of AAHKS and Viginia Orthopaedic Society. Golladay is an editorial/goverming board member of JOA and Arthroplasty Today. Golladay receives publishing royalties and financial/material support from Arthroplasty Today. Golladay receives IP royalties from Stryker. Thakkar is a board/committee member of AAHKS. Thakkar is an editorial/goverming board member of JOA and Arthroplasty Today. Thakkar is an unpaid consultant for KCI and OrthAlign. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Summary

Utilizing a data-driven analysis, this study found that the risk of fragility fractures in men starts to increase following the age of 70. To reduce the risk of these complications, physicians should ensure prompt diagnosis and treatment in men before the age of 70 to prevent these sentinel events.

Appendix

Appendix

Category

ICD or CPT billing code

routine primary care/family physician visit

CPT-99386, CPT-99387, CPT-99397, CPT-Z0000, CPT-Z0001

Fragility fractures (Fragility when excluding traumatic injury)

 

Spine fracture

ICD-9-D-80500, ICD-9-D-80501, ICD-9-D-80502, ICD-9-D-80503, ICD-9-D-80504, ICD-9-D-80505, ICD9-D-80506, ICD-9-D-80507, ICD-9-D-8052, ICD-9-D-8054, ICD-9-D-8058, ICD-9-D-8060, ICD-9-D80600:ICD-9-D-80609, ICD-9-D-80620:ICD-9-D-80629, ICD-9-D-8064, ICD-9-D-8068, ICD-9-D-73313, ICD-10-D-S129XXA, ICD-10-D-S12000A, ICD-10-D-S12001A, ICD-10-D-S12100A, ICD-10-DS12101A, ICD-10-D-S12200A, ICD-10-D-S12201A, ICD-10-D-S12300A, ICD-10-D-S12301A, ICD10-D-S12400A, ICD-10-D-S12401A, ICD-10-D-S12500A, ICD-10-D-S12501A, ICD-10-D-S12600A, ICD-10-D-S12601A, ICD-10-D-S22009A, ICD-10-D-S32009A, ICD-10-D-S3210XA, ICD-10-DS322XXA, ICD-10-D-S14101A, ICD-10-D-S14102A, ICD-10-D-S14103A, ICD-10-D-S14104A, ICD10-D-S14111A, ICD-10-D-S14112A, ICD-10-D-S14113A, ICD-10-D-S14114A, ICD-10-D-S14121A, ICD-10-D-S14122A, ICD-10-D-S14123A, ICD-10-D-S14124A, ICD-10-D-S14131A, ICD-10-DS14132A, ICD-10-D-S14133A, ICD-10-D-S14134A, ICD-10-D-S14151A, ICD-10-D-S14152A, ICD10-D-S14153A, ICD-10-D-S14154A, ICD-10-D-S14105A, ICD-10-D-S14106A, ICD-10-D-S14107A, ICD-10-D-S14115A, ICD-10-D-S14116A, ICD-10-D-S14117A, ICD-10-D-S14125A, ICD-10-DS14126A, ICD-10-D-S14127A, ICD-10-D-S14135A, ICD-10-D-S14136A, ICD-10-D-S14137A, ICD-10- D-S14155A, ICD-10-D-S14156A, ICD-10-D-S14157A, ICD-10-D-S24101A, ICD-10-D-S24102A, ICD10-D-S24111A, ICD-10-D-S24112A, ICD-10-D-S24131A, ICD-10-D-S24132A, ICD-10-D-S24151A, ICD-10-D-S24152A, ICD-10-D-S24103A, ICD-10-D-S24104A, ICD-10-D-S24113A, ICD-10-DS24114A, ICD-10-D-S24133A, ICD-10-D-S24134A, ICD-10-D-S24153A, ICD-10-D-S24154A, ICD-10- D-S34109A, ICD-10-D-S34119A, ICD-10-D-S34129A, ICD-10-D-S32009A, ICD-10-D-S34101A, ICD10-D-S34111A, ICD-10-D-S34121A, ICD-10-D-S32019A, ICD-10-D-S34102A, ICD-10-D-S34112A, ICD-10-D-S34122A, ICD-10-D-S32029A, ICD-10-D-S34103A, ICD-10-D-S34113A, ICD-10-DS34123A, ICD-10-D-S32039A, ICD-10-D-S34104A, ICD-10-D-S34114A, ICD-10-D-S34124A, ICD-10- D-S32049A, ICD-10-D-S34105A, ICD-10-D-S34115A, ICD-10-D-S34125A, ICD-10-D-S32059A, ICD10-D-S14109A, ICD-10-D-S24109A, ICD-10-D-S34109A, ICD-10-D-S34139A, ICD-10-D-M4850XA, ICD-10-D-M8008XA, ICD-10-D-M8448XA, ICD-10-D-M8468XA, ICD-9-D-73313, ICD-9-D-73315, ICD-10-D-M8008XA, ICD-10-D-M8088XA

Hip fracture

ICD-9-D-82000:ICD-9-D-82009, ICD-9-D-82020:ICD-9-D-82022, ICD-9-D-8208, ICD-9-D-73314, ICD10-D-S72001A, ICD-10-D-S72002A, ICD-10-D-S72009A, ICD-10-D-S72011A, ICD-10-D-S72012A, ICD-10-D-S72019A, ICD-10-D-S72021A, ICD-10-D-S72022A, ICD-10-D-S72023A, ICD-10-DS72031A, ICD-10-D-S72032A, ICD-10-D-S72033A, ICD-10-D-S72041A, ICD-10-D-S72042A, ICD-10- D-S72043A, ICD-10-D-S72091A, ICD-10-D-S72092A, ICD-10-D-S72099A, ICD-10-D-S72101A, ICD10-D-S72102A, ICD-10-D-S72109A, ICD-10-D-S72141A, ICD-10-D-S72142A, ICD-10-D-S72143A, ICD-10-D-S72231A, ICD-10-D-S72232A, ICD-10-D-S7223XA, ICD-10-D-M84451A, ICD-10-DM84452A, ICD-10-D-M84453A, ICD-10-D-M84459A, ICD-9-D-73314, ICD-10-D-M80051A, ICD-10- D-M80052A, ICD-10-D-M80059A, ICD-10-D-M80851A, ICD-10-D-M80852A, ICD-10-D-M80859A

Pelvic fracture

ICD-9-D-8080, ICD-9-D-8082, ICD-9-D-80841, ICD-9-D-80842, ICD-9-D-80849, ICD-9-D-8088, ICD10-D-S32401A, ICD-10-D-S32402A, ICD-10-D-S32409A, ICD-10-D-S32501A, ICD-10-D-S32502A, ICD-10-D-S32501A, ICD-10-D-S32502A, ICD-10-D-S32509A, ICD-10-D-S32301A, ICD-10-DS32302A, ICD-10-D-S32309A, ICD-10-D-S32601A, ICD-10-D-S32602A, ICD-10-D-S32609A, ICD10-D-S32810A, ICD-10-D-S32811A, ICD-10-D-S3282XA, ICD-10-D-S3289XA, ICD-10-D-S329XXA, ICD-10-D-M84454A

Wrist fracture

ICD-9-D-81340:ICD-9-D-81347, ICD-9-D-73312, ICD-10-D-S5290XA, ICD-10-D-S52531A, ICD-10-DS52532A, ICD-10-D-S52539A, ICD-10-D-S52541A, ICD-10-D-S52542A, ICD-10-D-S52549A, ICD10-D-S52501A, ICD-10-D-S52502A, ICD-10-D-S52509A, ICD-10-D-S52601A, ICD-10-D-S52602A, ICD-10-D-S52609A, ICD-10-D-S52111A, ICD-10-D-S52112A, ICD-10-D-S52119A, ICD-10-DS52521A, ICD-10-D-S52522A, ICD-10-D-S52529A, ICD-10-D-S52011A, ICD-10-D-S52012A, ICD-10- D-S52019A, ICD-10-D-S52621A, ICD-10-D-S52622A, ICD-10-D-S52629A, ICD-10-D-S52011A, ICD10-D-S52012A, ICD-10-D-S52019A, ICD-10-D-S52621A, ICD-10-D-A52622A, ICD-10-D-S52629A, ICD-10-D-M84431A, ICD-10-D-M84432A, ICD-10-D-M84439A, ICD-9-D-73312, ICD-10-D-M80031A, ICD-10-D-M80032A, ICD-10-D-M80039A, ICD-10-D-M80831A, ICD-10-D-M80832A, ICD-10-DM80839A

Humerus fracture

ICD-9-D-81200:ICD-9-D-81209, ICD-9-D-81220, ICD-9-D-81221, ICD-9-D-81240:ICD-9-D-81249, ICD9-D-73311, ICD-10-D-S42201A, ICD-10-D-S42202A, ICD-10-D-S42209A, ICD-10-D-S42211A, ICD10-D-S42212A, ICD-10-D-S42213A, ICD-10-D-S42214A, ICD-10-D-S42215A, ICD-10-D-S42216A, ICD-10-D-S42291A, ICD-10-D-S42292A, ICD-10-D-S42293A, ICD-10-D-S42294A, ICD-10-DS42295A, ICD-10-D-S42296A, ICD-10-D-S42251A, ICD-10-D-S42252A, ICD-10-D-S42253A, ICD10-D-S42254A, ICD-10-D-S42255A, ICD-10-D-S42256A, ICD-10-D-S42291A, ICD-10-D-S42292A, ICD-10-D-S42293A, ICD-10-D-S42294A, ICD-10-D-S42295A, ICD-10-D-S42296A, ICD-10-DS42301A, ICD-10-D-S42302A, ICD-10-D-S42309A, ICD-10-D-S42391A, ICD-10-D-S42392A, ICD-10- D-S42399A, ICD-10-D-S42401A, ICD-10-D-S42402A, ICD-10-D-S42409A, ICD-10-D-S42411A, ICD10-D-S42412A, ICD-10-D-S42413A, ICD-10-D-S42414A, ICD-10-D-S42415,A ICD-10-D-S42416A, ICD-10-D-S42431A, ICD-10-D-S42432A, ICD-10-D-S42433A, ICD-10-D-S42434A, ICD-10-DS42435A, ICD-10-D-S42436A, ICD-10-D-S42451A, ICD-10-D-S42452A, ICD-10-D-S42453A, ICD-10- D-S42454A, ICD-10-D-S42455A, ICD-10-D-S42456A, ICD-10-D-S42441A, ICD-10-D-S42442A, ICD10-D-S42443A, ICD-10-D-S42444A, ICD-10-D-S42445A, ICD-10-D-S42446A, ICD-10-D-S42461A, ICD-10-D-S42462A, ICD-10-D-S42463A, ICD-10-D-S42464A, ICD-10-D-S42465A, ICD-10-DS42466A, ICD-10-D-S42471A, ICD-10-D-S42472A, ICD-10-D-S42473A, ICD-10-D-S42474A, ICD-10- D-S42475A, ICD-10-D-S42476A, ICD-10-D-S42491A, ICD-10-D-S42492A, ICD-10-D-S42493A, ICD10-D-S42494A, ICD-10-D-S42495A, ICD-10-D-S42496A, ICD-10-D-M84421A, ICD-10-D-M84422A, ICD-10-D-M84429A, ICD-9-D-73311, ICD-10-D-M80011A, ICD-10-D-M80012A, ICD-10-D-M80019A, ICD-10-D-M80021A, ICD-10-D-M80022A, ICD-10-D-M80029A, ICD-10-D-M80811A, ICD-10-DM80812A, ICD-10-D-M80819A, ICD-10-D-M80821A, ICD-10-D-M80822A, ICD-10-D-M80829A

Other fracture

ICD-9-D-73310, ICD-9-D-73316, ICD-9-D-73319, ICD-10-D-M8000XA, ICD-10-D-M80041A, ICD-10- D-M80042A, ICD-10-D-M80049A, ICD-10-D-M80061A, ICD-10-D-M80062A, ICD-10-D-M80069A, ICD-10-D-M80071A, ICD-10-D-M80072A, ICD-10-D-M80079A, ICD-10-D-M8080XA, ICD-10-DM80841A, ICD-10-D-M80842A, ICD-10-D-M80849A, ICD-10-D-M80861A, ICD-10-D-M80862A, ICD10-D-M80869A, ICD-10-D-M80871A, ICD-10-D-M80872A, ICD-10-D-M80879A

Traumatic injury

ICD-9-D-E8120, ICD-9-D-E8121, ICD-9-D-E8199, ICD-9-D-E8190, ICD-9-D-E8160, ICD-9-DE8129, ICD-9-D-E8191, ICD-9-D-E8147, ICD-9-D-E8150, ICD-9-D-E8130, ICD-9-D-E8210, ICD-9-D-E8161, ICD-9-D-E8192, ICD-9-D-E8162, ICD-9-D-E8131, ICD-9-D-E8122, ICD-9-DE8219, ICD-9-D-E8151, ICD-9-D-E8136, ICD-9-D-E8181, ICD-9-D-E8189, ICD-9-D-E8197, ICD-9-D-E8259, ICD-9-D-E8212, ICD-9-D-E8180, ICD-9-D-E8250, ICD-9-D-E8171, ICD-9-DE8182, ICD-9-D-E8179, ICD-9-D-E8249, ICD-9-D-E8230, ICD-9-D-E8211, ICD-9-D-E8241, ICD-9-D-E8139, ICD-9-D-E8252, ICD-9-D-E8127, ICD-9-D-E8149, ICD-9-D-E8128, ICD-9-DE8152, ICD-9-D-E8198, ICD-9-D-E8251, ICD-9-D-E8169, ICD-9-D-E9885, ICD-9-D-E8187, ICD-9-D-E8159, ICD-9-D-E8257, ICD-9-D-E8146, ICD-9-D-E8132, ICD-9-D-E8123, ICD-9-DE8110, ICD-9-D-E8240, ICD-9-D-E8170, ICD-9-D-E8126, ICD-9-D-E8188, ICD-9-D-E8196, ICD-9-D-E8200, ICD-9-D-E8193, ICD-9-D-E8258, ICD-9-D-E8218, ICD-9-D-E8231, ICD-9-DE8220, ICD-9-D-E8158, ICD-9-D-E8163, ICD-9-D-E8227, ICD-9-D-E8111, ICD-9-D-E8209, ICD-9-D-E8140, ICD-9-D-E8248, ICD-9-D-E8217, ICD-9-D-E8138, ICD-9-D-E8183, ICD-9-DE8232, ICD-9-D-E8682, ICD-9-D-E8100, ICD-9-D-E8178, ICD-9-D-E8137, ICD-9-D-E8148, ICD-9-D-E8239, ICD-9-D-E8221, ICD-9-D-E8141, ICD-9-D-E8242, ICD-9-D-E8186, ICD-9-DE8229, ICD-9-D-E8237, ICD-9-D-E8172, ICD-9-D-E8119, ICD-9-D-E8133, ICD-9-D-E8216, ICD-9-D-E8124, ICD-9-D-E8177, ICD-9-D-E8213, ICD-9-D-E8168, ICD-9-D-E8101, ICD-9-DE8208, ICD-9-D-E8153, ICD-9-D-E8157, ICD-9-D-E8194, ICD-9-D-E8222, ICD-9-D-E8134, ICD-9-D-E8167, ICD-9-D-E8226, ICD-9-D-E8142, ICD-9-D-E8201, ICD-9-D-E8166, ICD-9-DE8109, ICD-9-D-E8154, ICD-9-D-E8174, ICD-9-D-E8256, ICD-9-D-E8156, ICD-9-D-E8238, ICD-9-D-E8253, ICD-9-D-E8143, ICD-9-D-E8228, ICD-9-D-E8195, ICD-9-D-E9820, ICD-9-DE8173, ICD-9-D-E8184, ICD-9-D-E8164, ICD-9-D-E8202, ICD-9-D-E8243, ICD-9-D-E8247, ICD-9-D-E8112, ICD-9-D-E8203, ICD-9-D-E8236, ICD-9-D-E8102, ICD-9-D-E8107, ICD-9-DE8103, ICD-9-D-E8104, ICD-9-D-E8106, ICD-9-D-E8108, ICD-9-D-E8113, ICD-9-D-E8114, ICD-9-D-E8115, ICD-9-D-E8118, ICD-9-D-E8125, ICD-9-D-E8135, ICD-9-D-E8144, ICD-9-DE8145, ICD-9-D-E8155, ICD-9-D-E8175, ICD-9-D-E8176, ICD-9-D-E8185, ICD-9-D-E8204, ICD-9-D-E8205, ICD-9-D-E8206, ICD-9-D-E8207, ICD-9-D-E8214, ICD-9-D-E8215, ICD-9-DE8223, ICD-9-D-E8224, ICD-9-D-E8225, ICD-9-D-E8233, ICD-9-D-E8234, ICD-9-D-E8244, ICD-9-D-E8245, ICD-9-D-E8246, ICD-9-D-E8254, ICD-9-D-E8255, ICD-9-D-E9871, ICD-9-DE8849, ICD-9-D-E8810, ICD-9-D-E8801, ICD-9-D-E882, ICD-9-D-E8850, ICD-9-D-E8839, ICD-9-D-E8853, ICD-9-D-E8854, ICD-9-D-E9879, ICD-9-D-E8800, ICD-9-D-E8811, ICD-9-DE8342, ICD-9-D-E8841, ICD-9-D-E8351, ICD-9-D-E8832, ICD-9-D-E8359, ICD-9-D-E8343, ICD-9-D-E8353, ICD-9-D-E8349, ICD-9-D-E8354, ICD-9-D-E8439, ICD-9-D-E8831, ICD-9-DE8339, ICD-9-D-E8041, ICD-9-D-E8341, ICD-9-D-E8348, ICD-9-D-E8260, ICD-9-D-E8261, ICD-9-D-E8262, ICD-9-D-E8263, ICD-9-D-E8264, ICD-9-D-E8268, ICD-9-D-E8269, ICD-9-DE8290, ICD-9-D-E8294, ICD-9-D-E8298, ICD-9-D-E8299, ICD-10-D-V0200XA, ICD-10-D-V0209XA, ICD-10-D-V0210XA, ICD-10-D-V0212XA, ICD-10-D-V0219XA, ICD-10-D-V0290XA, ICD-10-D-V0299XA, ICD-10-D-V0600XA, ICD-10-D-V0609XA, ICD-10-D-V0610XA, ICD-10-D-V0612XA, ICD-10-D-V0619XA, ICD-10-D-V0690XA, ICD-10-D-V0692XA, ICD-10-D-V0699XA, ICD-10-D-V0900XA, ICD-10-D-V0909XA, ICD-10-D-V0920XA, ICD-10-D-V0929XA, ICD-10-D-V120XXA, ICD-10-D-V121XXA, ICD-10-D-V122XXA, ICD-10-D-V123XXA, ICD-10-D-V124XXA, ICD-10-D-V125XXA, ICD-10-D-V129XXA, ICD-10-D-V160XXA, ICD-10-D-V162XXA, ICD-10-D-V163XXA, ICD-10-D-V164XXA, ICD-10-D-V169XXA, ICD-10-D-V1900XA, ICD-10-D-V1909XA, ICD-10-D-V1910XA, ICD-10-D-V1919XA, ICD-10-D-V1920XA, ICD-10-D-V1929XA, ICD-10-D-V1940XA, ICD-10-D-V1949XA, ICD-10-D-V1950XA, ICD-10-D-V1959XA, ICD-10-D-V1960XA, ICD-10-D-V1969XA, ICD-10-D-V220XXA, ICD-10-D-V221XXA, ICD-10-D-V222XXA, ICD-10-D-V223XXA, ICD-10-D-V224XXA, ICD-10-D-V225XXA, ICD-10-D-V229XXA, ICD-10-D-V240XXA, ICD-10-D-V241XXA, ICD-10-D-V244XXA, ICD-10-D-V245XXA, ICD-10-D-V249XXA, ICD-10-D-V250XXA, ICD-10-D-V254XXA, ICD-10-D-V255XXA, ICD-10-D-V259XXA, ICD-10-D-V260XXA, ICD-10-D-V261XXA, ICD-10-D-V262XXA, ICD-10-D-V263XXA, ICD-10-D-V264XXA, ICD-10-D-V265XXA, ICD-10-D-V269XXA, ICD-10-D-V2900XA, ICD-10-D-V2909XA, ICD-10-D-V2910XA, ICD-10-D-V2919XA, ICD-10-D-V2920XA, ICD-10-D-V2929XA, ICD-10-D-V2940XA, ICD-10-D-V2949XA, ICD-10-D-V2950XA, ICD-10-D-V2959XA, ICD-10-D-V2960XA, ICD-10-D-V2969XA, ICD-10-D-V2981XA, ICD-10-D-V300XXA, ICD-10-D-V302XXA, ICD-10-D-V306XXA, ICD-10-D-V307XXA, ICD-10-D-V309XXA, ICD-10-D-V310XXA, ICD-10-D-V315XXA, ICD-10-D-V320XXA, ICD-10-D-V321XXA, ICD-10-D-V322XXA, ICD-10-D-V325XXA, ICD-10-D-V326XXA, ICD-10-D-V327XXA, ICD-10-D-V329XXA, ICD-10-D-V330XXA, ICD-10-D-V331XXA, ICD-10-D-V335XXA, ICD-10-D-V336XXA, ICD-10-D-V339XXA, ICD-10-D-V342XXA, ICD-10-D-V343XXA, ICD-10-D-V346XXA, ICD-10-D-V349XXA, ICD-10-D-V353XXA, ICD-10-D-V356XXA, ICD-10-D-V360XXA, ICD-10-D-V361XXA, ICD-10-D-V363XXA, ICD-10-D-V365XXA, ICD-10-D-V366XXA, ICD-10-D-V369XXA, ICD-10-D-V370XXA, ICD-10-D-V371XXA, ICD-10-D-V373XXA, ICD-10-D-V375XXA, ICD-10-D-V376XXA, ICD-10-D-V377XXA, ICD-10-D-V379XXA, ICD-10-D-V380XXA, ICD-10-D-V381XXA, ICD-10-D-V383XXA, ICD-10-D-V384XXA, ICD-10-D-V385XXA, ICD-10-D-V386XXA, ICD-10-D-V389XXA, ICD-10-D-V3900XA, ICD-10-D-V3919XA, ICD-10-D-V3920XA, ICD-10-D-V393XXA, ICD-10-D-V3940XA, ICD-10-D-V3949XA, ICD-10-D-V3959XA, ICD-10-D-V3960XA, ICD-10-D-V3969XA, ICD-10-D-V3981XA, ICD-10-D-V3989XA, ICD-10-D-V399XXA, ICD-10-D-V420XXA, ICD-10-D-V421XXA, ICD-10-D-V422XXA, ICD-10-D-V424XXA, ICD-10-D-V425XXA, ICD-10-D-V426XXA, ICD-10-D-V427XXA, ICD-10-D-V429XXA, ICD-10-D-V460XXA, ICD-10-D-V461XXA, ICD-10-D-V462XXA, ICD-10-D-V463XXA, ICD-10-D-V464XXA, ICD-10-D-V465XXA, ICD-10-D-V466XXA, ICD-10-D-V467XXA, ICD-10-D-V469XXA, ICD-10-D-V4900XA, ICD-10-D-V4909XA, ICD-10-D-V4910XA, ICD-10-D-V4919XA, ICD-10-D-V4920XA, ICD-10-D-V4929XA, ICD-10-D-V4940XA, ICD-10-D-V4949XA, ICD-10-D-V4950XA, ICD-10-D-V4959XA, ICD-10-D-V4960XA, ICD-10-D-V4969XA, ICD-10-D-V525XXA, ICD-10-D-V526XXA, ICD-10-D-V529XXA, ICD-10-D-V561XXA, ICD-10-D-V564XXA, ICD-10-D-V565XXA, ICD-10-D-V566XXA, ICD-10-D-V567XXA, ICD-10-D-V569XXA, ICD-10-D-V5900XA, ICD-10-D-V5909XA, ICD-10-D-V5910XA, ICD-10-D-V5919XA, ICD-10-D-V5920XA, ICD-10-D-V5929XA, ICD-10-D-V5940XA, ICD-10-D-V5949XA, ICD-10-D-V5950XA, ICD-10-D-V5959XA, ICD-10-D-V5960XA, ICD-10-D-V5969XA, ICD-10-D-V621XXA, ICD-10-D-V624XXA, ICD-10-D-V629XXA, ICD-10-D-V665XXA, ICD-10-D-V666XXA, ICD-10-D-V667XXA, ICD-10-D-V6900XA, ICD-10-D-V6909XA, ICD-10-D-V6910XA, ICD-10-D-V6920XA, ICD-10-D-V6940XA, ICD-10-D-V6949XA, ICD-10-D-V6950XA, ICD-10-D-V6959XA, ICD-10-D-V6960XA, ICD-10-D-V721XXA, ICD-10-D-V722XXA, ICD-10-D-V723XXA, ICD-10-D-V724XXA, ICD-10-D-V726XXA, ICD-10-D-V760XXA, ICD-10-D-V761XXA, ICD-10-D-V762XXA, ICD-10-D-V763XXA, ICD-10-D-V764XXA, ICD-10-D-V765XXA, ICD-10-D-V766XXA, ICD-10-D-V769XXA, ICD-10-D-V7900XA, ICD-10-D-V7909XA, ICD-10-D-V7910XA, ICD-10-D-V7919XA, ICD-10-D-V7920XA, ICD-10-D-V7940XA, ICD-10-D-V7949XA, ICD-10-D-V7950XA, ICD-10-D-V7959XA, ICD-10-D-V7960XA, ICD-10-D-V7969XA, ICD-10-D-V8051XA, ICD-10-D-V8052XA, ICD-10-D-V80790A, ICD-10-D-V810XXA, ICD-10-D-V811XXA, ICD-10-D-V820XXA, ICD-10-D-V821XXA, ICD-10-D-V8609XA, ICD-10-D-V8619XA, ICD-10-D-V8629XA, ICD-10-D-V8639XA, ICD-10-D-V8649XA, ICD-10-D-V8659XA, ICD-10-D-V8669XA, ICD-10-D-V8679XA, ICD-10-D-V8699XA, ICD-10-D-V871XXA, ICD-10-D-V877XXA, ICD-10-D-V878XXA, ICD-10-D-V879XXA, ICD-10-D-V880XXA, ICD-10-D-V881XXA, ICD-10-D-V887XXA, ICD-10-D-V888XXA, ICD-10-D-V889XXA, ICD-10-D-V890XXA, ICD-10-D-V891XXA, ICD-10-D-V892XXA, ICD-10-D-V893XXA, ICD-10-D-X810XXA, ICD-10-D-X820XXA, ICD-10-D-X822XXA, ICD-10-D-X828XXA, ICD-10-D-Y020XXA, ICD-10-D-Y030XXA, ICD-10-D-Y038XXA, ICD-10-D-Y32XXXA, ICD-10-D-W002XXA, ICD-10-D-W1789XA, ICD-10-D-W1843XA, ICD-10-D-W109XXA, ICD-10-D-W11XXXA, ICD-10-D-W009XXA, ICD-10-D-W1781XA, ICD-10-D-W14XXXA, ICD-10-D-W132XXA, ICD-10-D-V00321A, ICD-10-D-W051XXA, ICD-10-D-W1782XA, ICD-10-D-V00121A, ICD-10-D-W001XXA, ICD-10-D-W138XXA, ICD-10-D-V00311A, ICD-10-D-W100XXA, ICD-10-D-W133XXA, ICD-10-D-W134XXA, ICD-10-D-W139XXA, ICD-10-D-W12XXXA, ICD-10-D-V00181A, ICD-10-D-W130XXA, ICD-10-D-V9339XA, ICD-10-D-W15XXXA, ICD-10-D-V00891A, ICD-10-D-W131XXA, ICD-10-D-W171XXA, ICD-10-D-V815XXA, ICD-10-D-W170XXA, ICD-10-D-W173XXA

Osteoporosis-related exclusion

 

Osteoporosis

ICD-9-D-73300, ICD-9-D-73301, ICD-9-D-73302, ICD-9-D-73303, ICD-9-D-73309, ICD-10-DM810, ICD-10-D-M818, ICD-10-D-M816

Osteoporosis medications

GENERIC_DRUG-ALENDRONATE_SODIUM, GENERIC_DRUG-ALENDRONATE_SODIUM/VITAMIN_D3, GENERIC_DRUG-RISEDRONATE_SOD/CALCIUM_CARB, GENERIC_DRUG-RISEDRONATE_SODIUM, GENERIC_DRUG-IBANDRONATE_SODIUM, GENERIC_DRUG-ZOLEDRONIC_ACID, DRUG-FOSAMAX, DRUG-FOSAMAX_PLUS_D, DRUG-ACTONEL, DRUG-ACTONEL_WITH_CALCIUM, DRUG-RECLAST, DRUG-BONIVA, GENERIC_DRUG-TERIPARATIDE, GENERIC_DRUG-ABALOPARATIDE, DRUG-TYMLOS, DRUG-FORTEO, GENERIC_DRUG-CALCITONIN_SALMON_SYNTHETIC, DRUG-CALCITONIN-SALMON,GENERIC_DRUG-RALOXIFENE_HCL,GENERIC_DRUG-ESTROGENS_CONJ/BAZEDOXIFENE, DRUG-EVISTA, DRUG-DUAVEE, GENERIC_DRUG-DENOSUMAB, DRUG-PROLIAGENERIC_DRUG-ALENDRONATE_SODIUM, GENERIC_DRUG-ALENDRONATE_SODIUM/VITAMIN_D3, GENERIC_DRUG-RISEDRONATE_SOD/CALCIUM_CARB, GENERIC_DRUG-RISEDRONATE_SODIUM, GENERIC_DRUG-IBANDRONATE_SODIUM, GENERIC_DRUG-ZOLEDRONIC_AC/MANNITOL/0.9NACL, GENERIC_DRUG-ZOLEDRONIC_ACID, GENERIC_DRUG-ZOLEDRONIC_ACID/MANNITOL&WATER, GENERIC_DRUG-ZOLEDRONIC_ACID/MANNITOL-WATER, GENERIC_DRUG-RALOXIFENE_HCL, GENERIC_DRUG-DENOSUMAB, GENERIC_DRUG-TERIPARATIDE, GENERIC_DRUG-ABALOPARATIDE, GENERIC_DRUG-CALCITONIN_SALMON_SYNTHETIC

DEXA screening

CPT-77080, CPT-77081, CPT-77085, CPT-77086

Other exclusion

 

Malignancy

ICD-9-D-1960: ICD-9-D-1999, ICD-10-D-C770: ICD-10-D-C809, ICD-9-D-1400: ICD-9-D-1729, ICD-9-D-1740: ICD-9-D-1959, ICD-10-D-C000: ICD-10-D-C269, ICD-10-D-C300: ICD-10-D-C349, ICD-10-D-C370: ICD-10-D-C419, ICD-10-D-C430: ICD-10-D-C439, ICD-10-D-C450: ICD-10-D-C589, ICD-10-D-C600: ICD-10-D-C769, ICD-10-D-C970: ICD-10-D-C979

High-risk cohorts

-

Smoker

ICD-9-D-3051, ICD-9-D-98984, ICD-10-D-F17200, ICD-10-D-F17201, ICD-10-D-F17210, ICD-10-D-F17211, ICD-10-D-F17220, ICD-10-D-F17221, ICD-10-D-F17290, ICD-10-D-F17291

Alcohol abuse/dependence

ICD-9-D-2652, ICD-9-D-2911: ICD-9-D-2913, ICD-9-D-2915: ICD-9-D-2919, ICD-9-D-3030, ICD-9-D-3039, ICD-9-D-3050, ICD-9-D-3575, ICD-9-D-4255, ICD-9-D-5353, ICD-9-D-5710: ICD-9-D-5713, ICD-9-D-9800: ICD-9-D-9809, ICD-9-D-V113, ICD-10-D-F10, ICD-10-D-E52, ICD-10-D-G621, ICD-10-D-I426, ICD-10-D-K292, ICD-10-D-K700, ICD-10-D-K703, ICD-10-D-K709, ICD-10-D-T510: ICD-10-D-T519, ICD-10-D-Z502, ICD-10-D-Z714, ICD-10-D-Z721

Chronic corticosteroid usage

ICD-10-D-Z7952, ICD-9-D-V5865

Metabolic conditions affecting sex hormones and bone mineral density

ICD-9-D-2532, ICD-10-D-E230, ICD-9-D-6961, ICD-10-D-L400, ICD-10-D-L401, ICD-10-D-L404, ICD-10-D-L4050, ICD-10- D-L408, ICD-10-D-L409, ICD-9-D-2552, ICD-10-D-E259, ICD-10-D-E250, ICD-10-D-E258, ICD-9-D-042, ICD-10-D-B20, ICD-9-D-5712, ICD-9-D-5715, ICD-10-D-K7030, ICD-10-D-K7031, ICD-10-D-K717, ICD-10- D-K7460, ICD-10-D-K7469, ICD-9-D-28243, ICD-9-D-28244, ICD-10-D-D560, ICD-10-D-D561, ICD-9-D-75651, ICD-10-D-Q780, ICD-9-D-28241, ICD-9-D-28242, ICD-9-D-28260, ICD-9-D-28263, ICD-9-D-28269, ICD-9-D28264, ICD-9-D-28268, ICD-10-D-D571, ICD-10-D-D57812, ICD-10-D-D57412, ICD-10-DD57212, ICD-10-D-D57411, ICD-10-D-D57811, ICD-10-D-D57211, ICD-10-D-D57419, ICD10-D-D5780, ICD-10-D-D5740, ICD-10-D-D57819, ICD-10-D-D57219, ICD-10-D-D5720, ICD-9-D-7103, ICD-9-D-7104, ICD-9-D-725, ICD-10-D-M3390, ICD-10-D-M3220, ICD-10-DM353, ICD-9-D-4465, ICD-9-D-4464, ICD-9-D-4460, ICD-10-D-M315, ICD-10-D-M316, ICD-10-DM3130, ICD-10-D-M3131, ICD-10-D-M317, ICD-10-D-M300, ICD-10-D-M301, ICD-9-D-340, ICD-10-D-G35, ICD-9-D-24290, ICD-9-D-24200, ICD-10-D-E0590, ICD-10-D-E0500, ICD-10-D-E0520, ICD10-D-E0591, ICD-9-D-5790, ICD-10-D-K900, ICD-9-D-7140, ICD-10-D-M069, CD-9-D-5550, ICD-9-D-5551, ICD-9-D-5552, ICD-9-D-5559, ICD-10-D-K5000, ICD-10-DK50011, ICD-10-D-K50012, ICD-10-D-K50013, ICD-10-D-K50014, ICD-10-D-K50018, ICD10-D-K50019, ICD-10-D-K5010, ICD-10-D-K50111, ICD-10-D-K50112, ICD-10-D-K50113, ICD-10-D-K50114, ICD-10-D-K50118, ICD-10-D-K50119, ICD-10-D-K5080, ICD-10-DK50811, ICD-10-D-K50812, ICD-10-D-K50813, ICD-10-D-K50814, ICD-10-D-K50818, ICD10-D-K50819, ICD-10-D-K5090, ICD-10-D-K50911, ICD-10-D-K50912, ICD-10-D-K50913, ICD-10-D-K50914, ICD-10-D-K50918, ICD-10-D-K50919, ICD-10-D-K5100, ICD-10-DK51011, ICD-10-D-K51012, ICD-10-D-K51013, ICD-10-D-K51014, ICD-10-D-K51018, ICD10-D-K51019, ICD-10-D-K5180, ICD-10-D-K51811, ICD-10-D-K51812, ICD-10-D-K51813, ICD-10-D-K51814, ICD-10-D-K51818, ICD-10-D-K51819, ICD-10-D-K5190, ICD-10-DK51911, ICD-10-D-K51912, ICD-10-D-K51913, ICD-10-D-K51914, ICD-10-D-K51918, ICD10-D-K51919, ICD-9-D-7100, ICD-10-D-M3210, ICD-10-D-M329, ICD-9-D-135, ICD-10-D-D860, ICD-10-D-D861, ICD-10-D-D862, ICD-10-D-D863, ICD-10-DD8687, ICD-9-D-2550, ICD-10-D-E240, ICD-10-D-E242, ICD-10-D-E244, ICD-10-D-E248, ICD-10-DE249, ICD-9-D-25200, ICD-9-D-25201, ICD-9-D-25202, ICD-9-D-25208, ICD-9-D-58881, ICD-10-DE210, ICD-10-D-E211, ICD-10-D-E212, ICD-10-D-E213, ICD-10-D-N2581, ICD-9-D-7310, ICD-9-D-7311, ICD-10-D-M880, ICD-10-D-M881, ICD-10-D-M88811, ICD-10- D-M88812, ICD-10-D-M88819, ICD-10-D-M88821, ICD-10-D-M88822, ICD-10-D-M88829, ICD-10-D-M88831, ICD-10-D-M88832, ICD-10-D-M88839, ICD-10-D-M88841, ICD-10-DM88849, ICD-10-D-M88851, ICD-10-D-M88852, ICD-10-D-M88859, ICD-10-D-M88861, ICD10-D-M88862, ICD-10-D-M88869, ICD-10-D-M88871, ICD-10-D-M88872, ICD-10-D-M8888, ICD-10-D-M8889, ICD-10-D-M889, ICD-10-D-M9060, ICD-10-D-M90621, ICD-10-DM90641, ICD-10-D-M90651, ICD-10-D-M90652, ICD-10-D-M90661, ICD-10-D-M90671, ICD10-D-M90672, ICD-10-D-M9068, ICD-10-D-M9069, ICD-9-D-5856, ICD-10-D-N186

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarwal, A., Tarawneh, O., Cohen, J. et al. The incremental risk of fragility fractures in aging men. Osteoporos Int 35, 495–503 (2024). https://doi.org/10.1007/s00198-023-06956-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-023-06956-8

Keywords

Navigation